Pregled po CROSBI profilu: Rajko Kušec (CROSBI Profil: 20354, MBZ: 81895)
Pronađeno 307 radova
-
1.Lucijanic, Marko; Veic, Petra; Aric, Ivona; Tupek, Katarina Marija; Soric, Ena; Sabljic, Anica; Vlasac Glasnovic, Josipa; Stoos-Veic, Tajana; Krecak, Ivan; Kusec, RajkoHigher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time // Annals of Hematology (2023) doi:10.1007/s00277-023-05305-3 (međunarodna recenzija, online first)
-
2.Lucijanic, Marko; Krecak, Ivan; Soric, Ena; Sabljic, Anica; Galusic, Davor; Holik, Hrvoje; Perisa, Vlatka; Peric, Martina Moric; Zekanovic, Ivan; Kusec, RajkoHigher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis // Biochemia Medica, 33 (2023), 2; 020901, 8 doi:10.11613/bm.2023.020901 (međunarodna recenzija, članak, znanstveni)
-
3.Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Kušec, RajkoPalpable spleen size is differently prognostic in primary and secondary myelofibrosis // Leukemia & lymphoma, 64 (2023), 4; 893-896 doi:10.1080/10428194.2023.2179360 (međunarodna recenzija, pismo, znanstveni)
-
4.Hasselbalch, Hans; Skov, Vibe; Kjær, Lasse; Larsen, Morten Kranker; Knudsen, Trine A.; Lucijanić, Marko; Kušec, RajkoRecombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives // Cancers, 14 (2022), 22; 5495, 14 doi:10.3390/cancers14225495 (međunarodna recenzija, članak, znanstveni)
-
5.Lucijanić, Marko; Huzjan Korunić, Renata; Sedinić, Martina; Kovačević, Stjepan; Atić, Armin; Pejša, Vlatko; Kušec, RajkoBaseline and progressive adipopenia in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features are associated with worse clinical outcomes // Leukemia & lymphoma, 63 (2022), 7; 1556-1565 doi:10.1080/10428194.2022.2034160 (međunarodna recenzija, članak, znanstveni)
-
6.Sabljić, Anica; Sedinić Lacko, Martina; Kušec, Rajko; Pejša, Vlatko; Lucijanić, MarkoNo Evident Prognostic Benefit of Statin Use in Diffuse Large B-Cell Lymphoma Patients with Unfavorable Disease Features Treated with R-DA- EPOCH // Pharmacology, 107 (2022), 11-12; 623-627 doi:10.1159/000526625 (međunarodna recenzija, kratko priopcenje, znanstveni)
-
7.Krečak, Ivan; Rončević, Pavle; Kursar, Marin; Lucijanić, Marko; Galušić, Davor; Mrđenović, Stefan; Morić Perić, Martina; Ivanko, Iva; Matijaca, Hana; Budimir, Josipa et al.Sistemska mastocitoza u Republici Hrvatskoj // Liječnički vjesnik, 144 (2022), 9-10; 306-313 doi:10.26800/lv-144-9-10-3 (domaća recenzija, članak, znanstveni)
-
8.Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Sabljić, Anica; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Kušec, RajkoEstimated Plasma Volume Status in Patients With Primary Myelofibrosis and Associated Thrombotic and Mortality Risks // Clinical Lymphoma, Myeloma & Leukemia 22 Suppl. 2: Society of Hematologic Oncology Tenth Annual Meeting
Houston (TX), Sjedinjene Američke Države, 2022. str. S341-S342 doi:10.1016/s2152-2650(22)01467-7 (predavanje, međunarodna recenzija, sažetak, znanstveni) -
9.Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Sabljić, Anica; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Kušec, RajkoPatients with post polycythemia vera myelofibrosis might experience increased thrombotic risk in comparison to primary and post essential thrombocythemia myelofibrosis // Leukemia research, 119 (2022), 106905, 4 doi:10.1016/j.leukres.2022.106905 (međunarodna recenzija, kratko priopcenje, znanstveni)
-
10.Lucijanic, Marko; Jurin, Ivana; Sedinic Lacko, Martina; Soric, Ena; Sabljic, Anica; Krecak, Ivan; Mitrovic, Josko; Marelic, Daniela; Kremer, Zvonimir; Hadzibegovic, Irzal et al.Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients // Thrombosis research, 214 (2022), 37-39 doi:10.1016/j.thromres.2022.04.009 (međunarodna recenzija, članak, znanstveni)
-
11.Lucijanić, Marko; Sorić, Ena; Sedinić Lacko, Martina; Sabljić, Anica; Krečak, Ivan; Bistrović, Petra; Jordan, Ana; Manola, Šime; Jakšić, Ozren; Lucijanić, Tomo et al.Gradual increase in red cell distribution width is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients // Journal of medical virology, 94 (2022), 8; 3509-3511 doi:10.1002/jmv.27785 (međunarodna recenzija, pismo, znanstveni)
-
12.Krečak, Ivan; Celić-Bunikić, Sandra; Skelin, Marko; Lucijanić, Marko; Verstovsek, Srdan; Kušec, RajkoConcomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate // Annals of hematology, 101 (2022), 8; 1885-1886 doi:10.1007/s00277-022-04839-2 (međunarodna recenzija, prikaz, znanstveni)
-
13.Lucijanić, Marko; Krečak, Ivan; Kušec, RajkoRenal disease associated with chronic myeloproliferative neoplasms // Expert review of hematology, 15 (2022), 2; 93-96 doi:10.1080/17474086.2022.2039117 (međunarodna recenzija, pregledni rad, znanstveni)
-
14.Lucijanić, Marko; Kušec, RajkoRuxolitinib withdrawal due to the COVID-19 // Leukemia, 35 (2021), 4; 1218-1218 doi:10.1038/s41375-021-01214-4 (međunarodna recenzija, komentar, ostalo)
-
15.Lucijanić, Marko; Huzjan Korunić, Renata; Sedinić, Martina; Kušec, Rajko; Pejša, VlatkoMore pronounced muscle loss during immunochemotherapy is associated with worse clinical outcomes in newly diagnosed patients with diffuse large B-cell lymphoma with unfavorable features // Therapeutics and clinical risk management, 17 (2021), 1037-1044 doi:10.2147/tcrm.s323749 (međunarodna recenzija, članak, znanstveni)
-
16.Lucijanić, Marko; Huzjan Korunić, Renata; Ivić, Marija; Fazlić Džankić, Amina; Kušec, Rajko; Pejša, VlatkoPerirenal and subcutaneous fat differently affect outcomes in newly diagnosed classical Hodgkin lymphoma patients // Hematological oncology, 39 (2021), 4; 575-579 doi:10.1002/hon.2887 (međunarodna recenzija, pismo uredniku, znanstveni)
-
17.Lucijanić, Marko; Huzjan Korunić, Renata; Sedinić, Martina; Kušec, Rajko; Pejša, VlatkoPrognostic impact of psoas muscle index in patients with diffuse large B-cell lymphoma might be dependent on the immunochemotherapy type // Leukemia & lymphoma, 62 (2021), 10; 2535-2538 doi:10.1080/10428194.2021.1919667 (međunarodna recenzija, pismo uredniku, znanstveni)
-
18.Lucijanić, Marko; Piskač Živković, Nevenka; Ivić, Marija; Sedinić, Martina; Brkljačić, Boris; Mutvar, Andrea; Atić, Armin; Rudan, Diana; Baršić, Bruno; Lukšić, Ivica et al.Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients // Wiener klinische Wochenschrift, 133 (2021), 23-24; 1281-1288 doi:10.1007/s00508-021-01973-1 (međunarodna recenzija, članak, znanstveni)
-
19.Đerek, Lovorka; Stančin, Nevenka; Šimac, Brankica; Imširović, Indira; Kmet, Marta; Žarak, Marko; Živković, Marcela; Kušec, RajkoIzazovi laboratorijske dijagnostike u pandemiji bolesti COVID-19 // COVID-19 u različitim kliničkim aspektima / Liječnički vjesnik, 143(Supl. 4) / Anić, Branimir (ur.).
Zagreb: Hrvatski liječnički zbor, 2021. str. 20-20 doi:10.26800/lv-143-supl4-3 (predavanje, domaća recenzija, sažetak, stručni) -
20.Galušić, DavorANALIZA AURORA KINAZA A / POLO KINAZA 1 SIGNALNOG PUTA U OBOLJELIH OD MIJELOFIBROZE, 2021., doktorska disertacija, Medicinski fakultet, Split
-
21.Kušec, Rajko; Čaržavec, Dubravka; Serventi- Seiwerth, Ranka; Sinčić-Petričević, Jasminka; Galušić, Davor; Grohovac, Dragana; Kursar, Marin; Krečak, Ivan; Lucijanić, Marko; Martinović, Marko et al.Smjernice za dijagnostiku i liječenje policitemije vere // Bilten Krohema, 13 (2021), 1; 32-35 (domaća recenzija, pregledni rad, znanstveni)
-
22.Lucijanić, Marko; Krečak, Ivan; Sorić, Ena; Sedinić, Martina; Sabljić, Anica; Đerek, Lovorka; Jakšić, Ozren; Kušec, RajkoThrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism // Blood Cancer Journal, 11 (2021), 189, 5 doi:10.1038/s41408-021-00585-2 (međunarodna recenzija, pismo uredniku, znanstveni)
-
23.Lucijanić, Marko; Krečak, Ivan; Verstovšek, Srdan; Sorić, Ena; Galušić, Davor; Holik, Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Kušec, RajkoHigher red blood cell distribution width predicts thrombosis risk in primary and secondary myelofibrosis // Annals of hematology, 101 (2021), 6; 1355-1357 doi:10.1007/s00277-021-04724-4 (međunarodna recenzija, pismo uredniku, znanstveni)
-
24.Lucijanić, Marko; Krečak, Ivan; Galušić, Davor; Sedinić, Martina; Holik Hrvoje; Periša, Vlatka; Morić Perić, Martina; Zekanović, Ivan; Štoos- Veić, Tajana; Pejša, Vlatko; Kušec, RajkoHigher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis // Wiener klinische Wochenschrift, 133 (2021), 3-4; 97-103 doi:10.1007/s00508-020-01802-x (međunarodna recenzija, članak, znanstveni)
-
25.Galusic, Davor; Lucijanic, Marko; Livun, Ana; Radman, Maja; Blaslov, Viktor; Vicelic Cutura, Lucana; Petric, Marija; Miljak, Antonija; Lucijanic, Jelena; Drmic Hofman, Irena; Kusec, RajkoHigher AURKA and PLK1 expression are associated with inferior overall survival in patients with myelofibrosis // Blood Cells, Molecules, and Diseases, 81 (2020), 102396; 1-5 doi:10.1016/j.bcmd.2019.102396 (međunarodna recenzija, članak, znanstveni)
